Atlanta, GA – Scibility Media – 11/07/2014.
This article discusses two companies: Planar Systems, Inc.(NASDAQ:PLNR) and Polypore International, Inc.(NYSE:PPO)
Planar Systems, Inc.(NASDAQ:PLNR) reported its fourth quarter fiscal 2014 financial results after the markets closed on Nov. 5th, 2014. The figures included an 18% increase in digital signage product sales from the third quarter and a 42% boost from the figure recorded during the same period of the previous fiscal year.
In response to these positive figures, Needham upgraded Planar Systems from a Hold to a Buy.
The company recorded a trading volume that was nearly ten times higher than its three month average on Nov. 5th, 2014. This stock has been gathering the interest of investors on Wall Street and even reached a new 52 week high of $7.05 yesterday.
Polypore International, Inc.(NYSE:PPO)also reported its third quarter financial results after the markets closed on Nov. 5th, 2014. The reported figures included sales totaling $165.5 million, a $13.5 million increase from the $152 million figure recorded during the same period of the previous fiscal year.
Like Planar Systems, this company also saw its trading price reach a new 52 week high of $54.40 yesterday. Additionally, Polypore also saw its trading volume spike to a figure of 3.5 million, more than twelve times its three month average volume of 288,309. This is clearly a stock that is capturing investor interest.
This North Carolina-based company develops and specialized markets microporous membranes for use in the separation and filtration processes.
EquiPress.com is a non-advertisement based network (currently in limited release) designed for investors to discover and communicate with publicly traded companies in real-time.
Sign-up for free now to experience the full benefits of EquiPress pre-launch.
Discover and communicate with companies you would otherwise never have seen based on your interests, company news, personalized news feeds, and one-on-one communications with no middle-men nor advertisements. Read our no advertisements pledge.
Can’t find your company on EquiPress? Send us an email to email@example.com and we will contact them for you.
Interested in a one month free trial? Get access to our private investor network, real-time news distribution, automatic disclaimers, corporate analytics, verified public profile, and industry-wide marketing of your corporate news.
Disclosure: EquiPress is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. EquiPress does not hold any equity or financial interest in any publicly traded company. EquiPress provides a uniform subscription based service to all publicly traded companies on a monthly basis at a rate of $495 to provide investor awareness. EquiPress receives only cash compensation from clients. Despite the relationship, EquiPress maintains a neutral stance (nonbiased) on any investment related opinions and exists solely for the purpose of allowing investors to communicate with the publicly traded companies in an effort to establish for themselves investment considerations. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor. Please visit www.equipress.com for complete risks and disclosures.